Most Active InvestorsFind investorsPricing
Start for free
Start for free
HT Capital logo

HT Capital

Asia, Beijing, China, Beijing

Description

Asset Management, Venture Capital, Fund of Funds

Investor Profile

HT Capital has backed more than 12 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 4 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States, China, Japan.
  • Strong thematic focus on Biotechnology, Health Care, Life Science.

Stage Focus

  • Series B (33%)
  • Series C (25%)
  • Series Unknown (17%)
  • Series A (17%)
  • Series D (8%)

Country Focus

  • United States (50%)
  • China (33%)
  • Japan (8%)
  • Israel (8%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Autonomous Vehicles
  • Manufacturing
  • Therapeutics
  • Biopharma
  • Pharmaceutical
  • Commercial
  • Apps
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does HT Capital frequently co-invest with?

MV
Morningside Ventures
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
ACME Capital
ACME Capital
North America, Florida, United States, Boca Raton
Co-Investments: 2
3H Health Investment
3H Health Investment
Asia, Hong Kong Island, Hong Kong, Cyberport
Co-Investments: 1
Loyal Valley Capital
Loyal Valley Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
3E Bioventures
3E Bioventures
Asia, Beijing, China, Beijing
Co-Investments: 1
EFung Capital
EFung Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 2
Octagon Capital Advisors
Octagon Capital Advisors
North America, New York, United States, New York
Co-Investments: 1
BioVenture
BioVenture
Asia, Jiangsu, China, Suzhou
Co-Investments: 1
Lilly Asia Ventures
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Panacea Venture
Panacea Venture
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 2

Which angels does HT Capital often collaborate with?

RO
Rohan Oza
North America, California, United States, Beverly Hills
Shared Deals: 1

What are some of recent deals done by HT Capital?

Uhnder

Austin, Texas, United States

Uhnder develops a digital automotive radar-on-chip designed to automate systems for safety and better feedback response.

AppsAutomotiveAutonomous VehiclesInternet of ThingsSemiconductor
Series DFeb 20, 2024
Amount Raised: $50,000,000
Kula Bio

Somerville, Massachusetts, United States

Kula Bio is a company that provides sustainable biological solutions for modern agriculture.

AgricultureBiotechnologyFarmingFood and Beverage
Series AJan 3, 2022
Amount Raised: $50,000,000
TriArm Therapeutics

Beijing, Beijing, China

TriArm Therapeutics is a developer of cellular immunotherapy products intended for the treatment of cancer patients.

BiotechnologyHealth Care
Series UnknownSep 27, 2021
Amount Raised: $60,000,000
Alebund Pharmaceuticals

Shanghai, Shanghai, China

Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases.

BiotechnologyLife SciencePharmaceutical
Series BSep 13, 2021
Amount Raised: $54,500,000
Inmagene Biopharmaceuticals

San Diego, California, United States

Inmagene is a clinical-stage biotech company developing innovative and differentiated therapies for immunological and inflammatory diseases.

BiopharmaBiotechnologyHealth Care
Series CJun 1, 2021
Amount Raised: $100,000,000
LandSpace

Beijing, Beijing, China

LandSpace is a Chinese company engaged in the development and operation of rockets.

Autonomous VehiclesCommercialManufacturing
Series CSep 9, 2020
Amount Raised: $175,610,613
TriArm Therapeutics

Beijing, Beijing, China

TriArm Therapeutics is a developer of cellular immunotherapy products intended for the treatment of cancer patients.

BiotechnologyHealth Care
Series AJul 19, 2019
Amount Raised: $20,000,000
Kyulux

Fukuoka, Fukuoka, Japan

Kyulux researches, develops, and manufactures organic light emitting diode (OLED) material.

Chemical EngineeringDeveloper PlatformManufacturing
Series BMay 27, 2019
Amount Raised: $31,959,603
OncoResponse

Seattle, Washington, United States

OncoResponse is an immuno-oncology biotech company developing cancer immunotherapies leveraging human immune system responses.

BiopharmaBiotechnologyHealth CareOncologyTherapeutics
Series BSep 11, 2018
Amount Raised: $40,000,000
Cue

San Diego, California, United States

Cue is a healthcare technology company that enables people to manage their health through actionable and connected health data.

Health CareHealth DiagnosticsLife ScienceMedicalWellness
Series BJul 10, 2018
Amount Raised: $45,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Most Active Investors Find InvestorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator